Stocks and Investing
Stocks and Investing
Wed, August 19, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 18, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Downgraded (UBX) to Hold and Held Target at $50 on, Aug 18th, 2020
Matthew Harrison of Morgan Stanley, Downgraded "Unity Biotechnology, Inc." (UBX) to Hold and Held Target at $50 on, Aug 18th, 2020.
Matthew has made no other calls on UBX in the last 4 months.
There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Monday, August 17th, 2020